Smn2B/- mice, the severe mouse model of SMA, express approximately 15% residual full-length SMN (FLSMN) compared to Smn2B/+ heterozygous mice (Eshraghi et al., 2016). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.